Antiviral inflammation during early pregnancy reduces placental and fetal growth trajectories

Journal of Immunology

Volumn 204, Issue 3, 2020, Pages 694-706

  Baines, Kelly J ^a   Rampersaud, Amanda M ^a   Hillier, Dendra M ^a   Jeyarajah, Mariyan J ^a   Grafham, Grace K ^a   Eastabrook, Genevieve ^b,c   Lacefield, James C ^b,d   Renaud, Stephen J ^a,c  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; INTERLEUKIN 6; POLYINOSINIC POLYCYTIDYLIC ACID; DLK1 PROTEIN, RAT; INTERFERON; MEMBRANE PROTEIN; SFRP2 PROTEIN, RAT; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; DLK1 GENE; EMBRYO DEVELOPMENT; EMBRYONIC AND PLACENTAL STRUCTURES; FEMALE; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; GENE; GENE REPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENOME IMPRINTING; GESTATIONAL AGE; GROWTH RETARDATION; HYPOXIA; IFNAR1 GENE; IFNAR2 GENE; INFLAMMATION; MEST GENE; NONHUMAN; PATHOGENESIS; PLACENTA DEVELOPMENT; PLACENTA INSUFFICIENCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SFRP2 GENE; SUSTAINED VIROLOGIC RESPONSE; TROPHOBLAST; UTERUS; VIRULENCE; ADVERSE EVENT; ANIMAL; CELL DIFFERENTIATION; FETUS DEVELOPMENT; GENETICS; IMMUNOLOGY; MATERNAL EXPOSURE; METABOLISM; PHYSIOLOGY; PLACENTA; PREGNANCY; SPRAGUE DAWLEY RAT; VIRUS INFECTION;

ANIMALS; CELL DIFFERENTIATION; FEMALE; FETAL DEVELOPMENT; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERFERONS; INTERLEUKIN-6; MATERNAL EXPOSURE; MEMBRANE PROTEINS; PLACENTA; PLACENTATION; POLY I-C; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; TROPHOBLASTS; VIRUS DISEASES;

EID: 85078554042     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1900888     Document Type: Article

References (73)

1. Romero, R., F. Gotsch, B. Pineles, and J. P. Kusanovic. 2007. Inflammation in pregnancy: Its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr. Rev. 65: S194-S202.
2. Cotechini, T., and C. H. Graham. 2015. Aberrant maternal inflammation as a cause of pregnancy complications: A potential therapeutic target? Placenta 36: 960-966.
3. Mor, G., I. Cardenas, V. Abrahams, and S. Guller. 2011. Inflammation and pregnancy: The role of the immune system at the implantation site. Ann. N. Y. Acad. Sci. 1221: 80-87.
4. Renaud, S. J., T. Cotechini, J. S. Quirt, S. K. Macdonald-Goodfellow, M. Othman, and C. H. Graham. 2011. Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J. Immunol. 186: 1799-1808.
5. Chatterjee, P., L. E. Weaver, K. M. Doersch, S. E. Kopriva, V. L. Chiasson, S. J. Allen, A. M. Narayanan, K. J. Young, K. A. Jones, T. J. Kuehl, and B. M. Mitchell. 2012. Placental Toll-like receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice. PLoS One 7: E41884.
6. Cotechini, T., M. Komisarenko, A. Sperou, S.Macdonald-Goodfellow, M. A. Adams, and C. H. Graham. 2014. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J. Exp. Med. 211: 165-179.
7. Bakos, J., R. Duncko, A. Makatsori, Z. Pirnik, A. Kiss, and D. Jezova. 2004. Prenatal immune challenge affects growth, behavior, and brain dopamine in offspring. Ann. N. Y. Acad. Sci. 1018: 281-287.
8. 2019. ACOG practice bulletin no. 204: Fetal growth restriction. Obstet. Gynecol. 133: E97-e109.
9. Brodsky, D., and H. Christou. 2004. Current concepts in intrauterine growth restriction. J. Intensive Care Med. 19: 307-319.
10. Sharma, D., S. Shastri, and P. Sharma. 2016. Intrauterine growth restriction: Antenatal and postnatal aspects. Clin. Med. Insights. Pediatr. 10: 67-83.
11. Raghupathy, R., M. Al-Azemi, and F. Azizieh. 2012. Intrauterine growth restriction: Cytokine profiles of trophoblast antigen-stimulated maternal lymphocytes. Clin. Dev. Immunol. 2012: 734865.
12. Sibley, C. P., P. Brownbill, M. Dilworth, and J. D. Glazier. 2010. Review: Adaptation in placental nutrient supply to meet fetal growth demand: Implications for programming. Placenta 31(Suppl.): S70-S74.
13. Baines, K. J., and S. J. Renaud. 2017. Transcription factors that regulate trophoblast development and function. Prog. Mol. Biol. Transl. Sci. 145: 39-88.
14. Soares, M. J., K. M. Varberg, and K. Iqbal. 2018. Hemochorial placentation: Development, function, and adaptations. Biol. Reprod. 99: 196-211.
15. Ain, R., L. N. Canham, and M. J. Soares. 2003. Gestation stage-dependent intrauterine trophoblast cell invasion in the rat and mouse: novel endocrine phenotype and regulation. Dev. Biol. 260: 176-190.
16. Athanassakis, I., L. Papadimitriou, G. Bouris, and S. Vassiliadis. 2000. Interferon-g induces differentiation of ectoplacental cone cells to phenotypically distinct trophoblasts. Dev. Comp. Immunol. 24: 663-672.
17. Hoshida, M. S., R. Gorjão, C. Lima, S. Daher, R. Curi, and E. Bevilacqua. 2007. Regulation of gene expression in mouse trophoblast cells by interferon-gamma. Placenta 28: 1059-1072.
18. Buchrieser, J., S. A. Degrelle, T. Couderc, Q. Nevers, O. Disson, C. Manet, D. A. Donahue, F. Porrot, K.-H. Hillion, E. Perthame, et al. 2019. IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise. Science 365: 176-180.
19. Palchetti, S., D. Starace, P. De Cesaris, A. Filippini, E. Ziparo, and A. Riccioli. 2015. Transfected poly(I:C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells. J. Biol. Chem. 290: 5470-5483.
20. Zavitsanou, K., C. K. Lim, T. Purves-Tyson, T. Karl, M. Kassiou, S. D. Banister, G. J. Guillemin, and C. S. Weickert. 2014. Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: Amelioration by COX-2 inhibition. Brain Behav. Immun. 41: 173-181.
21. Meyer, U., J. Feldon, M. Schedlowski, and B. K. Yee. 2005. Towards an immunoprecipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 29: 913-947.
22. Stridh, L., A. Mottahedin, M. E. Johansson, R. C. Valdez, F. Northington, X. Wang, and C. Mallard. 2013. Toll-like receptor-3 activation increases the vulnerability of the neonatal brain to hypoxia-ischemia. J. Neurosci. 33: 12041-12051.
23. Wang, A., S. D. Pope, J. S. Weinstein, S. Yu, C. Zhang, C. J. Booth, and R. Medzhitov. 2019. Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice. Proc. Natl. Acad. Sci. USA 116: 2200-2209.
24. Forrest, C. M., O. S. Khalil, M. Pisar, R. A. Smith, L. G. Darlington, and T. W. Stone. 2012. Prenatal activation of Toll-like receptors-3 by administration of the viral mimetic poly(I:C) changes synaptic proteins, N-methyl-D-aspartate receptors and neurogenesis markers in offspring. Mol. Brain 5: 22.
25. Schneider, C. A., W. S. Rasband, and K. W. Eliceiri. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9: 671-675.
26. Asanoma, K., M. A. K. Rumi, L. N. Kent, D. Chakraborty, S. J. Renaud, N. Wake, D.-S. Lee, K. Kubota, and M. J. Soares. 2011. FGF4-dependent stem cells derived from rat blastocysts differentiate along the trophoblast lineage. Dev. Biol. 351: 110-119.
27. Stirnweiss, A., A. Ksienzyk, K. Klages, U. Rand, M. Grashoff, H. Hauser, and A. Kröger. 2010. IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction. J. Immunol. 184: 5179-5185.
28. Wenta, N., H. Strauss, S. Meyer, and U. Vinkemeier. 2008. Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations. Proc. Natl. Acad. Sci. USA 105: 9238-9243.
29. Piedrahita, J. A. 2011. The role of imprinted genes in fetal growth abnormalities. Birth Defects Res. A. Clin. Mol. Teratol. 91: 682-692.
30. Thaxton, J. E., T. Nevers, E. O. Lippe, S. M. Blois, S. Saito, and S. Sharma. 2013. NKG2D blockade inhibits poly(I:C)-triggered fetal loss in wild type but not in IL-10-/- mice. J. Immunol. 190: 3639-3647.
31. Hsiao, E. Y., and P. H. Patterson. 2011. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav. Immun. 25: 604-615.
32. Kessous, R., B. Aricha-Tamir, A. Y. Weintraub, E. Sheiner, and R. Hershkovitz. 2014. Umbilical artery peak systolic velocity measurements for prediction of perinatal outcome among IUGR fetuses. J. Clin. Ultrasound 42: 405-410.
33. Silasi, M., I. Cardenas, J.-Y. Kwon, K. Racicot, P. Aldo, and G. Mor. 2015. Viral infections during pregnancy. Am. J. Reprod. Immunol. 73: 199-213.
34. Kourtis, A. P., J. S. Read, and D. J. Jamieson. 2014. Pregnancy and infection. N. Engl. J. Med. 370: 2211-2218.
35. Lin, Y., Y. Zeng, S. Zeng, and T. Wang. 2006. Potential role of toll-like receptor 3 in a murine model of polyinosinic-polycytidylic acid-induced embryo resorption. Fertil. Steril. 85(Suppl. 1): 1125-1129.
36. Yockey, L. J., K. A. Jurado, N. Arora, A. Millet, T. Rakib, K. M. Milano, A. K. Hastings, E. Fikrig, Y. Kong, T. L. Horvath, et al. 2018. Type I interferons instigate fetal demise after Zika virus infection. Sci. Immunol. 3: Eaao1680.
37. Ilievski, V., S.-J. Lu, and E. Hirsch. 2007. Activation of toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod. Sci. 14: 315-320.
38. Reisinger, S., D. Khan, E. Kong, A. Berger, A. Pollak, and D. D. Pollak. 2015. The poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery. Pharmacol. Ther. 149: 213-226.
39. Lundberg, A. M., S. K. Drexler, C. Monaco, L. M. Williams, S. M. Sacre, M. Feldmann, and B. M. Foxwell. 2007. Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: A phenomenon absent from murine cell systems. Blood 110: 3245-3252.
40. Szaba, F.M., M. Tighe, L. W. Kummer, K. G. Lanzer, J. M.Ward, P. Lanthier, I.-J. Kim, A. Kuki, M. A. Blackman, S. J. Thomas, and J.-S. Lin. 2018. Zika virus infection in immunocompetent pregnant mice causes fetal damage and placental pathology in the absence of fetal infection. PLoS Pathog. 14: E1006994.
41. Fleiss, B., F. Wong, F. Brownfoot, I. K. Shearer, O. Baud, D. W. Walker, P. Gressens, and M. Tolcos. 2019. Knowledge gaps and emerging research areas in intrauterine growth restriction-associated brain injury. Front. Endocrinol. (Lausanne) 10: 188.
42. Griffiths, P. D., and C. Baboonian. 1984. A prospective study of primary cytomegalovirus infection during pregnancy: Final report. Br. J. Obstet. Gynaecol. 91: 307-315.
43. Liu, T., X. Zheng, Q. Li, J. Chen, Z. Yin, J. Xiao, D. Zhang, W. Li, Y. Qiao, and S. Chen. 2015. Role of human cytomegalovirus in the proliferation and invasion of extravillous cytotrophoblasts isolated from early placentae. Int. J. Clin. Exp. Med. 8: 17248-17260.
44. Chou, D., Y. Ma, J. Zhang, C. McGrath, and S. Parry. 2006. Cytomegalovirus infection of trophoblast cells elicits an inflammatory response: A possible mechanism of placental dysfunction. Am. J. Obstet. Gynecol. 194: 535-541.
45. Arechavaleta-Velasco, F., Y. Ma, J. Zhang, C. M. McGrath, and S. Parry. 2006. Adeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia. Am. J. Pathol. 168: 1951-1959.
46. Miner, J. J., B. Cao, J. Govero, A. M. Smith, E. Fernandez, O. H. Cabrera, C. Garber, M. Noll, R. S. Klein, K. K. Noguchi, et al. 2016. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165: 1081-1091.
47. Yu, S.-X., F.-H. Zhou, W. Chen, G.-M. Jiang, C.-T. Du, G.-Q. Hu, Z.-Z. Liu, S.-Q. Yan, J.-M. Gu, X.-M. Deng, et al. 2017. Decidual stromal cell necroptosis contributes to polyinosinic-polycytidylic acid-triggered abnormal murine pregnancy. Front. Immunol. 8: 916.
48. McColl, E. R., and M. Piquette-Miller. 2019. Poly(I:C) alters placental and fetal brain amino acid transport in a rat model of maternal immune activation. Am. J. Reprod. Immunol. 81: E13115.
49. Petrovic, V., and M. Piquette-Miller. 2010. Impact of polyinosinic/polycytidylic acid on placental and hepatobiliary drug transporters in pregnant rats. Drug Metab. Dispos. 38: 1760-1766.
50. Lye, P., E. Bloise, M. Javam, W. Gibb, S. J. Lye, and S. G. Matthews. 2015. Impact of bacterial and viral challenge on multidrug resistance in first- and thirdtrimester human placenta. Am. J. Pathol. 185: 1666-1675.
51. Guilleret, I., M.-C. Osterheld, R. Braunschweig, V. Gastineau, S. Taillens, and J. Benhattar. 2009. Imprinting of tumor-suppressor genes in human placenta. Epigenetics 4: 62-68.
52. Wylie, A. A., S. K. Murphy, T. C. Orton, and R. L. Jirtle. 2000. Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation. Genome Res. 10: 1711-1718.
53. Lefebvre, L., S. Viville, S. C. Barton, F. Ishino, E. B. Keverne, and M. A. Surani. 1998. Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest. Nat. Genet. 20: 163-169.
54. McMinn, J., M. Wei, Y. Sadovsky, H. M. Thaker, and B. Tycko. 2006. Imprinting of PEG1/MEST isoform 2 in human placenta. Placenta 27: 119-126.
55. Bobetsis, Y. A., S. P. Barros, D. M. Lin, R. M. Arce, and S. Offenbacher. 2010. Altered gene expression in murine placentas in an infection-induced intrauterine growth restriction model: A microarray analysis. J. Reprod. Immunol. 85: 140-148.
56. Bobetsis, Y. A., S. P. Barros, D. M. Lin, J. R. Weidman, D. C. Dolinoy, R. L. Jirtle, K. A. Boggess, J. D. Beck, and S. Offenbacher. 2007. Bacterial infection promotes DNA hypermethylation. J. Dent. Res. 86: 169-174.
57. Schreiber, G., and J. Piehler. 2015. The molecular basis for functional plasticity in type I interferon signaling. Trends Immunol. 36: 139-149.
58. Racicot, K., P. Aldo, A. El-Guindy, J.-Y. Kwon, R. Romero, and G. Mor. 2017. Cutting edge: Fetal/placental type I IFN can affect maternal survival and fetal viral load during viral infection. J. Immunol. 198: 3029-3032.
59. Cappelletti, M., P. Presicce, M. J. Lawson, V. Chaturvedi, T. E. Stankiewicz, S. Vanoni, I. T. Harley, J. W. McAlees, D. A. Giles, M. E. Moreno-Fernandez, et al. 2017. Type I interferons regulate susceptibility to inflammation-induced preterm birth. JCI Insight 2: E91288.
60. Pietras, E. M., R. Lakshminarasimhan, J.-M. Techner, S. Fong, J. Flach, M. Binnewies, and E. Passegué. 2014. Re-entry into quiescence protects hematopoietic stem cells from the killing effect of chronic exposure to type I interferons. J. Exp. Med. 211: 245-262.
61. Smith, J. N. P., Y. Zhang, J. J. Li, A. McCabe, H. J. Jo, J. Maloney, and K. C. MacNamara. 2018. Type I IFNs drive hematopoietic stem and progenitor cell collapse via impaired proliferation and increased RIPK1-dependent cell death during shock-like ehrlichial infection. PLoS Pathog. 14: E1007234.
62. Eggenberger, J., D. Blanco-Melo, M. Panis, K. J. Brennand, and B. R. tenOever. 2019. Type I interferon response impairs differentiation potential of pluripotent stem cells. Proc. Natl. Acad. Sci. USA 116: 1384-1393.
63. Abrahams, V. M., T. M. Schaefer, J. V. Fahey, I. Visintin, J. A. Wright, P. B. Aldo, R. Romero, C. R. Wira, and G. Mor. 2006. Expression and secretion of antiviral factors by trophoblast cells following stimulation by the TLR-3 agonist, Poly(I: C). Hum. Reprod. 21: 2432-2439.
64. Jones, H. N., T. Jansson, and T. L. Powell. 2009. IL-6 stimulates system A amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am. J. Physiol. Cell Physiol. 297: C1228-C1235.
65. Hu, Y., R. Tan, C. D. MacCalman, G. Eastabrook, S.-H. Park, J. P. Dutz, and P. von Dadelszen. 2008. IFN-gamma-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: A role for insulin-like growth factors. Mol. Hum. Reprod. 14: 281-289.
66. Soares, M. J., D. Chakraborty, M. A. Karim Rumi, T. Konno, and S. J. Renaud. 2012. Rat placentation: An experimental model for investigating the hemochorial maternal-fetal interface. Placenta 33: 233-243.
67. La Torre, R., G. Nigro, M. Mazzocco, A. M. Best, and S. P. Adler. 2006. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin. Infect. Dis. 43: 994-1000.
68. Qaisar, N., S. Lin, G. Ryan, C. Yang, S. R. Oikemus, M. H. Brodsky, R. Bortell, J. P. Mordes, and J. P. Wang. 2017. A critical role for the type I interferon receptor in virus-induced autoimmune diabetes in rats. Diabetes 66: 145-157.
69. Bayer, A., N. J. Lennemann, Y. Ouyang, J. C. Bramley, S. Morosky, E. T. Marques, Jr., S. Cherry, Y. Sadovsky, and C. B. Coyne. 2016. Type III interferons produced by human placental trophoblasts confer protection against Zika virus infection. Cell Host Microbe 19: 705-712.
70. Steuerman, Y., M. Cohen, N. Peshes-Yaloz, L. Valadarsky, O. Cohn, E. David, A. Frishberg, L. Mayo, E. Bacharach, I. Amit, and I. Gat-Viks. 2018. Dissection of influenza infection in vivo by single-cell RNA sequencing. Cell Syst. 6: 679-691.e4.
71. Sheridan, M. A., D. Yunusov, V. Balaraman, A. P. Alexenko, S. Yabe, S. Verjovski-Almeida, D. J. Schust, A. W. Franz, Y. Sadovsky, T. Ezashi, and R. M. Roberts. 2017. Vulnerability of primitive human placental trophoblast to Zika virus. Proc. Natl. Acad. Sci. USA 114: E1587-E1596.
72. Kratimenos, P., and A. A. Penn. 2019. Placental programming of neuropsychiatric disease. Pediatr. Res. 86: 157-164.
73. Murray, E., M. Fernandes, M. Fazel, S. H. Kennedy, J. Villar, and A. Stein. 2015. Differential effect of intrauterine growth restriction on childhood neurodevelopment: A systematic review. BJOG 122: 1062-1072.